Literature DB >> 14585641

Eosinophilic-lymphocytic myocarditis after smallpox vaccination.

Joseph G Murphy1, R Scott Wright, G Keith Bruce, Larry M Baddour, Michael A Farrell, William D Edwards, Hirohito Kita, Leslie T Cooper.   

Abstract

Smallpox is an eradicated viral disease that has re-emerged as a potential bioterrorism threat. Smallpox vaccination was historically the most effective defence measure against wild smallpox virus. The risk of myopericarditis after vaccination might limit this option. We report a case of biopsy-proven eosinophilic-lymphocytic myocarditis diagnosed in vivo with histological evidence for eosinophil-mediated cardiac myocyte necrosis shortly after smallpox vaccination. Furthermore, we report a beneficial haemodynamic response to high-dose corticosteroids. A better understanding of the aberrant immune mechanism of myocyte injury after smallpox vaccination might improve the risk/benefit assessment for people considering smallpox vaccination and better smallpox vaccines in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585641     DOI: 10.1016/S0140-6736(03)14635-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine.

Authors:  Jeffrey I Cohen; Patricia Hohman; Rachael Fulton; Siu-Ping Turk; Jing Qin; Karen Thatcher; Ronald L Hornung
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

2.  Myocarditis secondary to smallpox vaccination.

Authors:  Kyle Keinath; Tyler Church; Benjamin Kurth; Edward Hulten
Journal:  BMJ Case Rep       Date:  2018-03-22

3.  LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.

Authors:  Masayuki Saijo; Yasushi Ami; Yuriko Suzaki; Noriyo Nagata; Naoko Iwata; Hideki Hasegawa; Momoko Ogata; Shuetsu Fukushi; Tetsuya Mizutani; Tetsutaro Sata; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination.

Authors:  Naoki Hoshino; Masanobu Yanase; Taisuke Ichiyasu; Kazuhiko Kuwahara; Hideki Kawai; Takashi Muramatsu; Hideki Ishii; Tetsuya Tsukamoto; Shin-Ichiro Morimoto; Hideo Izawa
Journal:  J Cardiol Cases       Date:  2022-07-04

5.  Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

Authors:  Markus Cornberg; Brian S Sheridan; Frances M Saccoccio; Michael A Brehm; Liisa K Selin
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.

Authors:  Ryan S Noyce; Seth Lederman; David H Evans
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

7.  Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant.

Authors:  Vivek Kumar; Navjyot Sidhu; Shuvendu Roy; K Gaurav
Journal:  Ann Pediatr Cardiol       Date:  2018 May-Aug

8.  Recurrent epicardial ventricular tachycardia following smallpox vaccination.

Authors:  Jeremy W Docekal; Gregory Francisco; Joseph C Lee
Journal:  HeartRhythm Case Rep       Date:  2018-09-25

9.  Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report.

Authors:  Peter Ehrlich; Karin Klingel; Susanne Ohlmann-Knafo; Sebastian Hüttinger; Nitin Sood; Dirk Pickuth; Michael Kindermann
Journal:  Clin Res Cardiol       Date:  2021-09-06       Impact factor: 5.460

Review 10.  COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.

Authors:  Sadeer Al-Kindi; David A Zidar
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.